Metastatic ovarian serous carcinoma presenting as inflammatory breast cancer: A case report

International Journal of Gynecological Pathology

Volumn 29, Issue 3, 2010, Pages 243-247

  Gingell, Dana ^a   Samuel, Amber ^a   Haynik, Denise ^a   McBee, William ^a   Kelley, Joseph ^a   Zorn, Kristin ^a   Bhargava, Rohit ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Clinical presentation; Immunohistochemistry; Inflammatory breast carcinoma; Metastatic ovarian carcinoma; Tumor morphology

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MASTECTOMY; MASTITIS; OVARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY;

ADULT; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BREAST NEOPLASMS; CA-125 ANTIGEN; CYSTADENOCARCINOMA, SEROUS; DNA, NEOPLASM; FEMALE; GENES, BRCA2; HISTOCYTOCHEMISTRY; HUMANS; OVARIAN NEOPLASMS;

EID: 77951716586     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181c18523     Document Type: Article

References (15)

1. Georgiannos SN, Chin J, Goode AW, et al. Secondary neoplasms of the breast: A survey of the 20th Century. Cancer 2001;92:2259-2266
2. Hejmadi RK, Day LJ, Young JA. Extramammary metastatic neoplasms in the breast: A cytomorphological study of 11 cases. Cytopathology 2003;14:191-194
3. Lee AH. The histological diagnosis of metastases to the breast from extramammary malignancies. J Clin Pathol 2007;60:1333-1341
4. Toombs BD, Kalisher L.Metastatic disease to the breast: clinical, pathologic, and radiographic features. AJR Am J Roentgenol 1977;129:673-676
5. Kayikcioglu F, Boran N, Ayhan A, et al. Inflammatory breast metastases of ovarian cancer: A case report. Gynecol Oncol 2001;83:613-616
6. Sato T, Muto I, Fushiki M, et al. Metastatic breast cancer from gastric and ovarian cancer, mimicking inflammatory breast cancer: report of two cases. Breast Cancer 2008;15: 315-320
7. Micha JP, Goldstein BH, Epstein HD, et al. Ovarian cancer metastatic to the breast. Gynecol Oncol 2006;102: 386-390
8. Khalifeh I, Deavers MT, Cristofanilli M, et al. Primary peritoneal serous carcinoma presenting as inflammatory breast cancer. Breast J 2009;15:176-181
9. Recine MA, Deavers MT, Middleton LP, et al. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: A potential pitfall. Am J Surg Pathol 2004;28:1646-1651
10. Nonaka D, Chiriboga L, Soslow RA. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 2008;32:1566-1571
11. Bhargava R, Beriwal S, Dabbs DJ. Mammaglobin versus GCDFP-15: An immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol 2007;127:103-113
12. Tornos C, Soslow R, Chen S, et al. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol 2005;29:1482-1489
13. Wick MR, Lillemoe TJ, Copland GT, et al. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol 1989;20:281-287
14. Domfeh AB, Carley AL, Striebel JM, et al. WT1 immunoreactivity in breast carcinoma: selective expression in pure and mixed mucinous subtypes. Mod Pathol 2008;21:1217-1223
15. Lee AH, Paish EC, Marchio C, et al. The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast. Histopathology 2007;51:824-828